Batoclimab as an add-on therapy in neuromyelitis optica spectrum disorder patients with acute attacks.
Wang Y, Zhong X, Wang H, Peng Y, Shi F, Jia D, Yang H, Zeng Q, Quan C, ZhangBao J, Lee M, Qi J, Chen X, Qiu W; Batoclimab NMOSD Study Group.
Wang Y, et al. Among authors: chen x.
Eur J Neurol. 2023 Jan;30(1):195-203. doi: 10.1111/ene.15561. Epub 2022 Sep 25.
Eur J Neurol. 2023.
PMID: 36087008
Clinical Trial.